22 related articles for article (PubMed ID: 2113148)
1. Anti-renal cell carcinoma chimeric antibody G250: cytokine enhancement of in vitro antibody-dependent cellular cytotoxicity.
Liu Z; Smyth FE; Renner C; Lee FT; Oosterwijk E; Scott AM
Cancer Immunol Immunother; 2002 May; 51(3):171-7. PubMed ID: 11941456
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of antitumor effect on mouse hepatocellular carcinoma by intratumoral injection of OK-432, a streptococcal preparation.
Homma S; Sagawa Y; Komita H; Koido S; Nagasaki E; Ryoma Y; Okamoto M
Cancer Immunol Immunother; 2007 Aug; 56(8):1265-74. PubMed ID: 17219148
[TBL] [Abstract][Full Text] [Related]
3. Induction of tumor growth inhibitory factor (TGIF) in human mononuclear cells by OK-432, a streptococcal preparation.
Katano M; Yamamoto H; Mizoguchi T; Hisatsugu T
Cancer Immunol Immunother; 1988; 27(3):198-204. PubMed ID: 3141056
[TBL] [Abstract][Full Text] [Related]
4. Phase IB trial of picibanil (OK-432) as an immunomodulator in patients with resected high-risk melanoma.
Kirkwood JM; Wilson J; Whiteside TL; Donnelly S; Herberman RB
Cancer Immunol Immunother; 1997 May; 44(3):137-49. PubMed ID: 9191873
[TBL] [Abstract][Full Text] [Related]
5. Cytokines produced by blood mononuclear cells stimulated with the streptococcal preparation OK-432: effect on production by supplementing the medium with xenogeneic serum.
Fujii M; Abo T; Kumagai K
Cancer Immunol Immunother; 1988; 27(2):97-102. PubMed ID: 2458183
[TBL] [Abstract][Full Text] [Related]
6. Clinical studies on cell-mediated immunity in patients with renal cell carcinoma: interleukin-2 and interferon-gamma production of lymphocytes.
Ikemoto S; Wada S; Kamizuru M; Hayahara N; Kishimoto T; Maekawa M
Cancer Immunol Immunother; 1992; 34(5):289-93. PubMed ID: 1540974
[TBL] [Abstract][Full Text] [Related]
7. Sensitivity of fresh and cultured ovarian tumor cells to tumor necrosis factor, interferon-alpha 2, and OK-432.
Nio Y; Zighelboim J; Berek JS; Bonavida B
Cancer Immunol Immunother; 1988; 27(3):246-54. PubMed ID: 3180149
[TBL] [Abstract][Full Text] [Related]
8. Direct and indirect effects of human interferon alpha on renal cell carcinoma: a new in vitro assay system for evaluating cytokine-mediated antitumor effects.
Matsuyama H; Yoshihiro S; Ohmoto Y; Yamamoto N; Naito K
Cancer Immunol Immunother; 1993 Jul; 37(2):84-8. PubMed ID: 8319245
[TBL] [Abstract][Full Text] [Related]
9. A randomized phase II trial comparing two different sequence combinations of autologous vaccine and human recombinant interferon gamma and human recombinant interferon alpha2B therapy in patients with metastatic renal cell carcinoma: clinical outcome and analysis of immunological parameters.
Schwaab T; Heaney JA; Schned AR; Harris RD; Cole BF; Noelle RJ; Phillips DM; Stempkowski L; Ernstoff MS
J Urol; 2000 Apr; 163(4):1322-7. PubMed ID: 10737537
[TBL] [Abstract][Full Text] [Related]
10. Combination therapy for renal cell carcinoma using IFN-gamma and OK-432: in vitro study.
Muraki J
Keio J Med; 1990 Mar; 39(1):21-5. PubMed ID: 2113148
[TBL] [Abstract][Full Text] [Related]
11. [Sequential combination therapy with alpha interferon and OK-432 (streptococcal preparation) against advanced renal cell carcinoma].
Marumo K; Mura M; Deguchi N; Baba S; Jitsukawa S; Nakazono M; Tazaki H
Gan To Kagaku Ryoho; 1986 Jul; 13(7):2434-9. PubMed ID: 3729498
[TBL] [Abstract][Full Text] [Related]
12. The streptococcal preparation OK-432 specifically augments the susceptibility of human urinary bladder tumor cells to autologous peripheral blood lymphocytes.
Mizutani Y; Nio Y; Yoshida O
Cancer; 1992 Jun; 69(12):2999-3007. PubMed ID: 1591693
[TBL] [Abstract][Full Text] [Related]
13. [Effect of selective intra-arterial infusion of OK-432 against renal cell cancers].
Fujioka T; Tanji S; Koike H; Kumagai K; Suzuki K; Aoki H; Banya Y; Kubo T; Ohhori T
Hinyokika Kiyo; 1987 Jun; 33(6):832-7. PubMed ID: 3673835
[TBL] [Abstract][Full Text] [Related]
14. [A case of advanced renal cell carcinoma achieved complete response by a sequential combination therapy with gamma interferon and OK-432 (streptococcal preparation)].
Nakamura S; Marumo K; Shibayama T; Baba S; Deguchi N; Tazaki H
Nihon Hinyokika Gakkai Zasshi; 1988 Jun; 79(6):1103-7. PubMed ID: 3141666
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
